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Salicylaldehyde derived hexadentate Schiff base N,N‟-Bis[2-salicylideneamino]ethane-1,2-diamine (TTS) and its 
complexes with Fe(III), Co(II) and Cu(II) metal ions have been prepared and characterised by elemental analysis, UV-
visible, IR, 1H NMR, EPR spectral analysis, mass spectrometry and XRD method. In vitro antibacterial activity of the Schiff 
base and its metal complexes against Gram positive bacterial strains Staphylococus aureus, Bacillus subtilis and Gram 
negative bacterial strains Enterobacter, Escherichia coli has revealed that the metal complexes are more active to the 
bacterial strains as compared to that of the Schiff base. The Co-TTS has the highest antibacterial activity against Escherichia 
coli, while the Fe-TTS complex is highly active against Enterobacter, Staphylococcus aureus and Bacillus subtilis. 
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Schiff bases have drawn attention in both chemistry 
and biology for selective and specific complexation 
with metal ions
1,2
. Schiff base transition metal 
complexes have been of great interest in co-ordination 
chemistry for many years due to their facile synthesis
3
 
and wide applications in the development of catalysts 
and enzyme catalytic reactions, pharmaceuticals, and 
material chemistry
4-6
. These complexes are used in 












. A comprehensive literature 
survey indicates that among the bio-essential metals, 
iron, cobalt and copper complexes of Schiff base are 
considered as promising biologically active agents. 
Recently, several copper and cobalt complexes of 
Schiff base have been reported as potential anticancer 
and chemotherapeutic agents and some copper 
complexes have been established to be active both in 
vitro and in vivo
15-17
. Schiff bases are used for the 
synthesis of ionophores and these ionophores are used 
in separation of metal ions by extraction and liquid 
membrane transport methods
18-23
. There are numerous 
examples of the pentadentate and hexadentate Schiff 
base metal complexes derived from the reaction of 
metal salts with salicylaldehyde and polyamines
24-26
.  
In this piece of work, hexadentate Schiff base 
(TTS) and its complexes with Fe(III), Co(II) and 
Cu(II) metal ions have been synthesized, 
characterised and screened for their in vitro 
antibacterial activity against Gram positive bacterial 
strains Staphylococus aureus, Bacillus subtilis, and 
Gram negative bacterial strains Enterobacter, 
Escherichia coli. 
Materials and Methods 
Chemicals 
Salicylaldehyde and triethylenetetramine (TETA) 
were purchased from Loba Chemie and S.D. Fine, 
respectively. Metal salts FeCl3, Co(NO3)2.3H2O 
and Cu(CH3COO)2 were obtained from CDH. 
Dimethylsulphoxide (DMSO), ethanol and methanol 
were obtained from Merck and used without further 
purification. 
Instruments 
Melting point was determined by capillary melting 
point apparatus. IR spectra were recorded using 
Shimadzu 8400 FT-IR spectrometer in the range of 
4000-600 cm
-1
 at Central Analytical Laboratories, 
Indore. 
1
H NMR spectra were recorded on Brucker 
Avance II 400 NMR spectrometer using 
tetramethylsilane (TMS) as an internal standard at 
Sophisticated Analytical Instrumentation Facility 
(SAIF), Punjab University, Chandigarh. Elemental 
analysis (CHN) was carried out using Eurovector EA 
3000 Elemental Analyzer and mass spectra were 




recorded on positive ESI mode using Waters UPLC-
TQD Mass Spectrometer at SAIF, Lucknow UP. The 
X-ray diffraction (XRD) pattern of Fe-TTS was 
recorded on Bruker d8 advance X-ray diffractometer 
using CuKα radiation (λ = 1.5406 Å), 40 kV, 40 MA, 
2θ/θ scanning mode at UGC-DAE Consortium for 
Scientific Research, Indore. EPR spectra were recorded 
on JES-FA200 at SAIF, IIT Madras, Chennai. 
 
Preparation of Schiff base (TTS) 
The Schiff base (TTS) was synthesized by the 
reaction of salicylaldehyde with TETA in 2:1 molar 
ratio
27
. The solution of salicylaldehyde (10.48 mL, 
0.10 mol) in ethanol (25 mL) was refluxed with 
solution of TETA (7.5 mL, 0.05 mol) in ethanol (25 
mL) in the presence of 1 mL acetic acid at 80 °C for  
4 h in a round bottom flask. After cooling the solution 
in the ice bath, yellow crystals obtained, which were 
filtered, washed with hexane followed with water and 
recrystallised with ethanol (Scheme 1). Yield: 78%. 
Melting point: 110 °C. Solubility: soluble in 
methanol, chloroform, DMF, DMSO and hot ethanol. 
Elemental analysis: for C20H26N4O2 calculated (%): C 
67.8, H, 7.4; N, 15.8, found (%): C 72.9, H 10.1, N 
18.0. IR (cm
-1
): 3550 (N-H), 3380 (O-H), 2923, 2850  
(C-H), 1631 (C=N). 
1
H NMR (CDCl3, ppm): 8.34  
(s, 2H, CH=N), 6.80-7.33 (m, 8H, Ar-H),  
2.59-3.73 (m, 12H, CH2-N), 1.23 (m, 2H, -NH-). ESI 
+ MS (m/z) for C20H26N4O2: calculated 354.45,  
found 355. 
 
Preparation of Metal complexes 
The metal complexes (Fig. 1) were prepared from 
the reaction of the metal salts FeCl3, Co(NO3)2.3H2O 
and Cu(CH3COO)2 with the salicylaldehyde and 
TETA in mole ratio 1:2:1 in methanol. 
 
Preparation of Fe(III)-TTS complex 
Salicylaldehyde (1 mL, 0.010 mol) was mixed  
with TETA (0.75 mL, 0.005 mol) in methanol  
(50 mL) in a round bottom flask. The solution turns 
yellow immediately. After 5 min, solution of  
FeCl3 (1.35 g, 0.005 mol) in methanol (30 mL) was 
added drop wise to the Schiff base suspension. The 
reaction mixture was refluxed for 2 h, filtered and 
kept at room temperature for slow evaporation of the 
solvent. Dark blue crystals were obtained
28-30
. Yield: 
51.99%. Melting point: 165 °C. Solubility: Soluble  
in water and DMSO. Elemental analysis: for 
C20H24N4O2Fe, calculated (%): C 58.9, H 5.9,  
N 13.7; found (%): C 56.3, H 5.4, N 15.3. IR (cm
-1
): 
3475, 3407, 3324, 3166 (C-H), 1627 (C=N).  
ESI + MS (m/z) for (C20H24N4O2Fe): calculated 
408.27, found 408. 
 
 
Scheme 1 ― Synthesis of Schiff base (TTS) 
 
 
Fig. 1 ― Structure of Metal complex of Schiff base 




Preparation of Co(II)-TTS complex 
Salicylaldehyde (1 mL, 0.010 mol) was mixed with 
Co(NO3)2.3H2O (1.185 g, 0.005 mol) in methanol  
(60 mL) in a round bottom flask and stirred for 5 min. 
To this, solution of TETA (0.75 mL, 0.005 mol) in 
methanol (40 mL) was added drop wise and refluxed 
for 2 h. Black precipitates obtained, which were 
filtered, washed with methanol and dried in air
31, 32
. 
Yield: 46.02%. Melting point: 218 °C. Solubility: 
Soluble in DMSO. Elemental analysis: for 
C20H24N4O2Co, calculated (%): C 58.3, H 5.9, N 13.6; 
found (%): C 50.9, H 7.3, N 19.2. IR (cm
-1
):  
3387, 3166, 2934 (C-H), 1636 (C=N). ESI + MS 
(m/z) for (C20H24N4O2Co): calculated 411.36,  
found 411. 
 
Preparation of Cu(II)-TTS complex 
Salicylaldehyde (1 mL, 0.010 mol) was mixed with 
anhydrous Cu(CH3COO)2 (1.0 g, 0.005 mol) at 80 °C 
in methanol (50 mL) in a round bottom flask and 
stirred for 5 min. To this, solution of TETA (0.75 mL, 
0.005 mol) in methanol (40 mL) was added drop wise 
and stirred at room temperature for 1 h. Brown 
crystals obtained, which were filtered, washed with 
methanol and dried in air
24, 30, 33, 34
. Yield: 21.66%. 
Melting point: greater than 300 °C. Solubility: soluble 
in DMSO. Elemental analysis : for C20H24N4O2Cu, 
calculated (%): C 57.7, H 5.8, N 13.5; found (%): C 
46.4, H 6.5, N 11.8. IR (cm
-1
): 3490, 3050 (C-H), 
1625 (C=N). ESI + MS (m/z) for (C20H24N4O2Cu): 
calculated 415.97, found 416.08. 
 
In vitro antibacterial activity 
Antibacterial activity of Schiff base and its metal 
complexes in DMSO was tested in triplicate against 
Gram positive bacterial strains Staphylococus aureus, 
Bacillus subtilis and Gram negative bacterial strains 
Enterobacter, Escherichia coli by the Agar well 
diffusion method. The wells of 6 mm center were dug 
in the media with the help of a sterile metallic borer. 
Recommended volume 50 µL of the test sample of 
different concentrations 10, 30, 50 mg/mL was 
introduced in the respective wells. The plates were 
incubated immediately at 37 C for 24 h. Activity was 
determined by measuring the diameter of zones 
showing complete inhibition (mm). Two standard 
drugs (antibiotics), Ampicillin (Zycillin-500) and 
Amoxycillin (MOX-500) were also screened against 
these bacterial strains for comparison. To examine the 
effect of DMSO on biological growth, separate 
studies were conducted with DMSO which showed no 




Results and Discussion 
Characterization of complexes 
Physical properties of Schiff base and its metal 
complexes are reported in Table 1. The FT-IR spectra 
of Schiff base and its metal complexes are shown in 
Supplementary Data, Figs S1-S4. The characteristic 
band at 1631 cm
-1 
for azomethine group (C=N) of 
Schiff base in Fig. S1 confirms the formation of 
Schiff base by condensation of keto group of 
salicylaldehyde and amino group of TETA while in 
Figs S2-S4, that band is shifted at 1627, 1636 and 
1625 cm
-1
 for Fe(III), Co(II) and Cu(II) complexes, 
respectively, suggesting the involvement of nitrogen 
atom of azomethine group to coordinate metal ions. 
The absorption band at 3380 cm
-1
 is assigned for 
phenolic group (-OH) in Schiff base and disappeared 
in metal complexes suggesting the deprotonation of 
oxygen of phenolic group and chelation of 





H NMR spectrum of Schiff base 
(Supplementary Data, Fig. S5) shows a characterstic 
signal in the region 10-13 ppm (hump) for phenolic 
group (-OH), a peak at 8.34 ppm for azomethine 
group (C=N) and a complex multiplet in the region 
6.80-7.33 ppm for aromatic protons, confirm the 
formation of Schiff base by condensation reaction of 
salicylaldehyde and TETA. 
ESI mass spectra of Schiff base and its metal 
complexes support the proposed structures and 
composition (Fig. 1, Scheme 2 and Table 1). The 
mass spectra of Schiff base, Fe-TTS, Co-TTS and Cu-
TTS (Supplementary Data, Fig. S6-S9) shows 
molecular ion peak at m/z 355 (calculated 354.45), 
408 (calculated 408.27), 411 (calculated 411.36) and 
Table 1 ― Physical properties of Schiff base (TTS) and its metal complexes 
Synthesized Compound Colour Stoichiometry % Yield Melting point 
(°C) 
Molecular Formula Molecular Weight 
Calculated Found 
TTS Yellow - 78.00 110 C20H26N4O2 354.45 355 
Fe-TTS Dark blue 1:1 51.99 165 C20H24N4O2Fe 408.27 408 
Co-TTS Black 1:1 46.02 218 C20H24N4O2Co 411.36 411 
Cu-TTS Brown 1:1 21.66 >300 C20H24N4O2Cu 415.97 416.08 




416.08 (calculated 415.97) corresponding to the 
molecular composition C20H26N4O2, C20H24N4O2Fe, 
C20H24N4O2Co and C20H24N4O2Cu, respectively. The 
results show 1:1 ratio of metal to Schiff base in 
complexes. 
The UV-visible spectra of Schiff base and metal 
complexes were recorded in methanol. The Schiff 
base exhibited intense bands in 200-400 nm region, it 
shows band at 254 nm assigned to π-π* electronic 
transition of phenyl ring, another band at 315 nm and 
398 nm assigned to π-π* and n-π* electronic 
transition for imine (C=N) group, respectively. 
However in the Fe(III), Co(II) and Cu(II) complexes, 
the shift in π-π* transition band of phenyl ring and 
imine group was observed along with extra absorption 
band at 495, 572 and 574 nm with disappearance of 
band at 398 nm due to the coordination of the 
azomethine nitrogen atom (nitrogen lone pair of 
electron donation), corresponding to d-d transition, 
confirm the co-ordination of metal ion to Schiff base 
(Table 2 and Supplementary Data, Fig. S10)
37-39
.  
The XRD pattern shown in Fig. 2 has been 
compared with the standard powder diffraction card 
of JCPDS iron file no. 70-1517, five peaks at 2θ value 
of 14.7719, 21.6466, 29.7143, 34.7895 and 45.1825 ° 
in the experimental diffractogram have been 
identified and corresponding h k l values (4 1 0),  
(1 2 1), (3 3 1), (5 1 2) and (3 4 2) planes are labeled. 
The XRD study confirmed that the prepared Fe-TTS 
has monoclinic crystal lattice. 
The average crystalline particle size „D‟ of Fe-TTS 
has been estimated from the Fig. 2 using Debye-
Scherrer formula, D = 0.9λ/βcosθ, where λ is 
wavelength of the X-rays used for diffraction and β is 
full width at half maximum (FWHM) of a peak. To 
estimate FWHM, each of the five peaks was fitted 
with a Gaussian function. The FWHM of the fitted 
Gaussian curve is taken as FWHM of the peak. This 
could be done by OriginPro 8.5 software, five values 
of the „D‟ have been obtained from the data 
(Supplementary Data, Table S1) corresponding to the 
selected peaks. The average crystalline particle size of 
Fe-TTS is found to be 136.41 nm. The values of the 
interplanar spacing „d‟ between the atoms have been 
calculated using Bragg‟s law. The average interplanar 





Scheme 2 ― Mass analysis of Schiff base (TTS) 
 




Characteristic electronic transition (nm) 
π-π* 
 (Phenyl ring) 




Transition due to M-L 
Coordination  
TTS 201, 254 315 398 - 
Fe-TTS 209, 231 336 - 495 
Co-TTS 209, 259 339 - 572 
Cu-TTS 207, 266 341 - 574 






Fig. 2 ― XRD plot of Fe-TTS 
 
The EPR spectra of Fe-TTS, Co-TTS and Cu-TTS 
complexes were recorded at 77 K (Fig. 3). The gavg 
values for Fe-TTS, Co-TTS and Cu-TTS complexes 
are 2.12, 2.15 and 2.12, respectively, which indicate 
distorted octahedral geometry around Fe(III), Co(II) 
and Cu(II) ions in these complexes, Three anisotropic 
signals are observed for Fe-TTS complex and four 
anisotropic signals are observed for Co-TTS and  
Cu-TTS complexes. From the observed g-values of 
these complexes, it is clear that gII > g⊥ which 
indicates that the unpaired electron is predominantly 
present in the dx2–y2 orbital and is the characteristic 
feature for the axial symmetry. The observed data 
showed that the gII values are greater than 2.0023 in 
complexes and hence the metal-ligand bondings in 
these complexes are essentially covalent. The average 
“g” value for overall distortion is calculated using the 




In vitro antibacterial activity 
The measured zone of inhibition against the growth 
of various bacterial strains is listed in Table 3 & 4 and 
presented in Fig. 4 and in Supplementary Data  
(Figs S11-S14). It is found that metal complexes  
have higher antibacterial activity as compared to  
that of Schiff base. Such increased activity of metal 
complexes can be explained on the basis of 
Overtone‟s concept of cell permeability. According to 
this concept, the lipid membrane that surrounds the 
cell favours the passage of only lipid soluble material 
due to which lipid solubility is considered to be an 
important factor that control antibacterial activity. 
After complexation, the polarity of metal ion will be 
reduced to a greater extent due to the overlap of 
ligand orbital and partial sharing of positive charge of  
 
 
Fig. 3 ― EPR spectra of Fe-TTS (a), Co-TTS (b) and Cu-TTS (c) 
 
metal ion with donor groups. Further, it increases the 
π- electron delocalization over the whole ring and 
enhances the lipophilicity of the complex. As shown 
in Fig. 1, metal ion after complexation with schiff 
base form pseudocyclic structure which enhances 
lipophilicity, hence the penetration of the complexes 
into lipid membrane increases and blocks the metal 




binding sites on enzyme of microorganism. These 
metal complexes also disturb the respiration process 
of the cell and block the synthesis of proteins, which 
restricts further growth of the organism. The variation 
in the activity of different complexes against different 
organisms depend either on the impermeability of the 
cells of the microbes or difference in ribosomes of 
microbial cells
44-48
. However, compared with the 
standard drug (antibiotics) Ampicillin (Zycillin-500) 
and Amoxycillin (MOX-500) the activity exerted by 
Schiff base and metal complexes are found to be less. 
Further it was observed that Schiff base and metal 
complexes are more active towards Gram negative 
bacterial strains compared to Gram positive bacterial 
strains, which depends on the composition of bacterial 
cell wall, as Gram negative bacteria have 
lipopolysaccharide layer in its cell wall, it may cause 
easy passage of Schiff base and metal complexes into 
the cell which restrict bacterial growth
49-51
. 
It is clear from Table 3 that the antibacterial 
activity of synthesized complexes against bacterial 
strains increases with increase in concentration 
however the Fe-TTS complex shows activity even at 
low concentration (10 mg/mL) as Fe-TTS complex is 
highly soluble in solvent as compare to other 
complexes. Co-TTS shows highest activity against 
Escherichia coli, Cu-TTS has least antibacterial 
activity against all bacterial strains while Fe-TTS is 
highly active against Enterobacter, Staphylococcus 
aureus and Bacillus subtilis. 
Table 4 ― Antibacterial activity of standards (antibiotics) 
Ampicillin (Zycillin-500) and Amoxycillin (MOX-500) 
Bacteria Zone of inhibition (mm) 




Dilution (mg/mL) 10  30  50  10  30  50  
Enterobacter 25 32 37 13 20 29 
Escherichia coli 27 35 40 15 21 30 
Staphylococcus 
aureus 
24 30 36 20 26 35 
Bacillus subtilis 22 28 35 18 25 35 
 
Conclusions 
Hexadentate Schiff base and its Fe(III), Co(II) and 
Cu(II) complexes have been prepared and characterized 
using different characterization techniques. The 
characterization studies revealed that the Schiff base 
(TTS) co-ordinate to the metal ion in 1:1 ratio through 
the phenolic oxygen and nitrogen atom. Metal 
complexes are biologically more active than that of 
Schiff base. Highest in vitro antibacterial activity 
observed with Fe-TTS complex against Enterobacter, 
Staphylococcus aureus and Bacillus subtilis while the 
Co-TTS complex has the highest activity against 
Escherichia coli. Schiff base and metal complexes are 
more active towards Gram negative bacterial strains 
compared to Gram positive bacterial strains. 
 
Supplementary Data 
Supplementary data associated with this  
article are available in the electronic form at 
 
 
Fig. 4 ― Antibacterial activity of synthesized compounds against (a) Staphylococcus aureus, (b) Bacillus subtilis, (c) Enterobacter and 
(d) Escherichia coli 
 








We would like to thank Dr. V. Ganeshan, Director 
UGC-DAE, Indore, for allowing us to utilize available 
facilities, Dr. Mukul Gupta, Scientist-F, UGC-DAE, 
Indore for providing XRD facilities and Prof. D. M. 
Kumawat, Head, School of Studies in Environmental 
Management, Vikram University, Ujjain (M.P.) for 
antibacterial activity. We are thankful to SAIF, 
Chandigarh for 
1
H NMR & elemental analysis and 
SAIF, IIT Madras for EPR analysis. 
 
References 
1 Iftikhar B, Javed K, Khan M S U, Akhter Z, Mirza B & 
McKee V, J Mol Struct, 1155 (2018) 337. 
2 Warad I, Ali O, Ali A A, Jaradat N A, Hussein F, Abdallah L, 
Al-Zaqri N, Alsalme A & Alharthi F A, Molecules,  
25 (2020) 2253. 
3 Chantarasiri N, Ruangpornvisuti V, Muangsin N, Detsen H, 
Mananunsap T, Batiya C & Chaichit N, J Mol Struct,  
701 (2004) 93.  
4 Garnovskii A D, Nivorozhkin A L & Minkin V I, Coord 
Chem Rev, 126 (1993) 1. 
5 Archer R A, Coord Chem Rev, 128 (1993) 49. 
6 Kaliyappan T & Kannan P, Prog Polym Sci, 25 (2000) 343. 
7 Wang M, Wang L F, Li Y Z, Li Q X, Xu Z D & Qu D M, 
Transit Met Chem, 26 (2001) 307.  
8 Ommenya F K, Nyawade E A, Andala D M & Kinyua J,  
J Chem, (2020) Article ID 1745236. 
9 Musa M A, Khan M O F, Aspedon A & Cooperwood J S, 
Lett Drug Des Discov, 7 (2010) 165. 
10 Nair M S, Kumari S S & Neelakantan M A, J Coord Chem, 
60 (2007) 1291.  
11 Tarasconi P, Capacchi S Pelosi G, Cornia M, Albertini R, 
Bonati A, Dall'Aglio P P, Lunghi P & Pinelli S, Bioorg Med 
Chem, 8 (2000) 157. 
12 Charo J, Lindencrona J A, Carlson L M, Hinkula J & 
Kiessling R, J Virol, 78 (2004) 11321.  
13 Muller J G, Paikoff S J, Rokita S E & Burrows C J, J Inorg 
Biochem, 54 (1994) 199. 
14 Inba P J K, Annaraj B, Thalamuthu S & Neelakantan M A, 
Bioinorg Chem Appl, (2013) Article ID 439848. 
15 Kupwade R V & Sawant V J, J Chem Sci, 132 (2020) 44. 
16 Subarkhan M M, Prabhu R N, Kumar R R & Ramesh R, RSC 
Adv, 6 (2016) 25082. 
17 Lian W J, Wang X T, Xie C Z, Tian H, Song X Q, Pan H T, 
Qiao X & Xu J Y, Dalton Trans, 45 (2016) 9073. 
18 Dubey S, Joshi N & Sharma U, Main Group Met Chem, 31 
(2008) 211. 
19 Dubey S, Joshi N & Sharma U, Rev Inorg Chem, 29 (2009) 103. 
20 Anchaliya D & Sharma U, Natl Acad Sci Lett, 35 (2012) 277. 
21 Anchaliya D & Sharma U, J Incl Phenom Macrocycl Chem, 
79 (2014) 465. 
22 Anchaliya D & Sharma U, Main Group Met Chem, 40 (2017) 27. 
23 Awasthy A, Bhatnagar M, Tomar J & Sharma U, Bioinorg 
Chem Appl, (2006) Article ID 097141. 
24 Yaftian M R, Rayati S, Safarbali R, Torabi N & Khavasi H 
R Transit Met Chem, 32 (2007) 374. 
25 Ocak U, Alp H, Ocak M & Gokce P, Sep Sci Technol,  
41 (2006) 391. 
26 Mukharjee P, Biswal C, Drew M G B & Ghosh A, 
Polyhedron, 26 (2007) 3121. 
27 Baran Y & Erk B, Turk J Chem, 20 (1996) 312. 
28 Ahmed R M, Yousif E I, Hasan A H & A1-Jeboori M J,  
Sci World J, (2013) Article ID 289805.  
29 Nemec I, Herchel R, Salitros I, Travnicek Z, Moncol J,  
Fuess H, Ruben M & Linert W, CrystEngComm,  
14 (2012) 7015. 
30 Martinho P N, Harding C J, Bunz H M, Martin A & Morgan 
G G, Eur J Inorg Chem, 5 (2010) 675. 
31 Raman N, Kulandaisamy A, Shunmugasundaram A & 
Jeyasubramanian K, Transit Met Chem, 26 (2001) 131. 
32 Singh R V, Dwivedi R & Joshi S C, Transit Met Chem,  
29 (2004) 70. 
33 Singh R V, Joshi S C, Gajraj A & Nagpal P, Appl Organomet 
Chem, 16 (2002) 713. 
34 Mohamed G G, Zayed M A & Abdallah S M, J Mol Struct, 
979 (2010) 62. 
35 Ismail T M A, Saleh A A & Ghamry M A E, Spectrochim 
Acta Part A, 86 (2012) 276. 
36 Kasumov V T, Yerli Y, Kutluay A & Aslanoglu M, 
Spectrochim Acta, Part A, 104 (2013) 203. 
37 Pavia D L, Lampman G M, Kriz G S & Vyvyan J A, 
Introduction to Spectroscopy, (Cengage Learning) 2008. 
38 Zarenezhad E & Esmaielzadeh S, Acta Chim Slov, 65 (2018) 
416. 
39 Asadi M, Asadi Z, Savaripoor N, Dusek M, Eigner V, 
Shorkaei M R & Sedaghat M, Spectrochim Acta Part A, 136 
(2015) 625. 
40 Sharma R, Acharya A D, Moghe S, Shrivastava S B, 
Gangrade M, Shripathi T & Ganesan V, Mat Sci Semicon 
Proc, 23 (2014) 42. 
41 Mehta B K, Chhajlani M & Shrivastava B D, J Phys Conf 
Series, 836 (2017) 012050. 
42 Soundaranayaki V, Kulandaisamy A & Arunadevi A, Inorg 
Chem Commun, 122 (2020) 108271. 
43 Savithri K, Kumar B C V, Vivek H K & Revanasiddappa H 
D, Int J Spectrosc, (2018) Article ID 8759372. 
44 Bera M, Mukhopadhyay U & Ray D, Inorganica Chim Acta, 
358 (2005) 437. 
45 Keypour H, Shayesteh M, Sharifi-Rad A, Salehzadeh S, 
Khavasi H & Valenika L, J Organomet Chem, 693 (19) 
(2008) 3179. 
46 Chandra S & Kumar R, Spectochim Acta Part A, 61(3) 
(2005) 437. 
47 Manimohan M, Pugalmani S & Sithique M A, J Inorg 
Organomet Polym Mater, 30 (2020) 4481.  
48 Devi J, Yadav M, Kumar A & Kumar A, Chem Papers,  
72 (2018) 2479. 
49 Fernández-G J M , López-Durán F A , Hernández-Ortega S , 
Gómez-Vidales V, Macı́as-Ruvalcaba N & Aguilar-Martı́nez 
M, J Mol Struct, 612 (2002) 69. 
50 Willey J M, Sandman K M & Wood D H, Presscott’s 
Microbiology, (McGraw Hills Offices), 2017. 
51 Pelczar M J, Chan E C S & Krieg N R, Microbiology, 
(McGraw Hills Offices), 2007. 
 
